Growth Metrics

Tenax Therapeutics (TENX) Total Non-Current Liabilities (2016 - 2017)

Historic Total Non-Current Liabilities for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $802474.0.

  • Tenax Therapeutics' Total Non-Current Liabilities fell 9368.57% to $802474.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $802474.0, marking a year-over-year decrease of 9368.57%. This contributed to the annual value of $6.0 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Tenax Therapeutics reported Total Non-Current Liabilities of $802474.0 as of Q3 2017, which was down 9368.57% from $2.1 million recorded in Q2 2017.
  • Tenax Therapeutics' 5-year Total Non-Current Liabilities high stood at $12.9 million for Q2 2016, and its period low was $802474.0 during Q3 2017.
  • Its 4-year average for Total Non-Current Liabilities is $6.8 million, with a median of $5.0 million in 2017.
  • In the last 5 years, Tenax Therapeutics' Total Non-Current Liabilities plummeted by 5038.66% in 2016 and then crashed by 9368.57% in 2017.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Total Non-Current Liabilities stood at $4.9 million in 2013, then soared by 145.5% to $12.0 million in 2015, then tumbled by 50.39% to $6.0 million in 2016, then plummeted by 86.57% to $802474.0 in 2017.
  • Its Total Non-Current Liabilities stands at $802474.0 for Q3 2017, versus $2.1 million for Q2 2017 and $5.0 million for Q1 2017.